Joseph Swedish - International Business Independent Director
| IBM Stock | EUR 217.90 2.05 0.93% |
Director
Mr. Joseph R. Swedish is Independent Director of the company. Mr. Swedish joined Anthem in 2013 as chief executive officer and was named chairman of Anthems board in 2015. He was the chairman, chief executive officer and president until late 2017 when he retired and became the executive chairman, a position he held until his retirement in May 2018. Prior to joining Anthem, he was the division president of Hospital Corporation of America from 1993 to 1998, president and chief executive officer of Centura Health from 1999 to 2004 and then served as president and chief executive officer of Trinity Health Corporation from 2004 to 2013. Mr. Swedish is a director of Centrexion Therapeutics and Mesoblast Limited. He also served as a director of the Blue Cross Blue Shield Association, the National Institute for Health Care Management, the Central Indiana Corporationrationrate Partnership, Inc. and as a member of the Business Roundtable. Mr. Swedish currently serves as chairman of the Board of Visitors of Duke Universitys Fuqua School of Business and was the past chairman of Americas Health Insurance Plans. He is a graduate member of The Business Council and a member of the Duke Margolis External Advisory Board. He is also a director of CDW Corporation and Proteus Digital Health, Inc. Mr. Swedish also serves as CoFounder Partner at Concord Health Partners, a private equity firm focused on strategic investing in healthcare portfolio companies. since 2017.
| Age | 67 |
| Tenure | 7 years |
International Business Leadership Team
Elected by the shareholders, the International Business' board of directors comprises two types of representatives: International Business inside directors who are chosen from within the company, and outside directors, selected externally and held independent of International. The board's role is to monitor International Business' management team and ensure that shareholders' interests are well served. International Business' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, International Business' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Liveris, Independent Director | ||
| Kenneth Keverian, Senior Vice President - Corporate Strategy | ||
| Gary Cohn, Vice Chairman | ||
| Alex Gorsky, Independent Director | ||
| Frederick Waddell, Independent Director | ||
| Arvind Krishna, Senior Vice President - Cloud and Cognitive Software | ||
| Robert Bene, Vice President Controller | ||
| James Kavanaugh, Senior Vice President, Chief Financial Officer, Finance and operation | ||
| Diane Gherson, Chief Human Resource Officer, Senior Vice President | ||
| Sidney Taurel, Independent Director | ||
| Virginia Rometty, Chairman of the Board, President, Chief Executive Officer | ||
| Peter Voser, Independent Director | ||
| John Kelly, Senior Vice President Director - Research | ||
| Michelle Howard, Independent Director | ||
| James Whitehurst, President | ||
| David Farr, Independent Director | ||
| Joseph Swedish, Independent Director | ||
| Michelle Browdy, Senior Vice President - Legal and Regulatory Affairs and General Counsel | ||
| Michael Eskew, Lead Independent Director | ||
| Martin Schroeter, CFO, Senior Vice President - Finance and Enterprise Transformation | ||
| Martha Pollack, Independent Director | ||
| Frederick McNabb, Independent Director | ||
| Thomas Buberl, Director |
International Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is International Business a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 171.15 B | |||
| Price To Book | 6.69 X | |||
| Price To Sales | 2.21 X | |||
| Revenue | 60.53 B | |||
| EBITDA | 7.17 B | |||
| Net Income | 1.64 B | |||
| Total Debt | 46.19 B | |||
| Cash Flow From Operations | 10.44 B | |||
| Price To Earnings To Growth | 1.26 X | |||
| Number Of Employees | 45 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in International Stock
When determining whether International Business is a strong investment it is important to analyze International Business' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact International Business' future performance. For an informed investment choice regarding International Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in International Business Machines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.